Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With Respiratory Decompensation
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine whether additional surfactant(Infasurf) doses at 7
to 10 days of life time will improve lung function in premature infants, allowing a decrease
in required oxygen concentration and ventilator settings.
Phase:
N/A
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborators:
University of Pennsylvania Women & Children's Hospital of Buffalo